Literature DB >> 32934

The assessment of antichymotrypsin in cancer monitoring.

U L Kelly, E H Cooper, C Alexander, J Stone.   

Abstract

A comparative study of serum antichymotrypsin, acid glycoprotein and antitrypsin levels has been made in various cancers. Antichymotrypsin (ACT) shows a non-specific elevation in metastatic cancer, and the response reflects tumour progression in a similar fashion to the other two acute phase reactant proteins. The main advantage of ACT as a marker appears to be its Normal distribution in health, and lack of phenotypic variation.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 32934

Source DB:  PubMed          Journal:  Biomedicine        ISSN: 0300-0893


  3 in total

1.  Molecular cloning reveals isoforms of bovine alpha 1-antichymotrypsin.

Authors:  S R Hwang; A B Kohn; V Y Hook
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

2.  Alpha 1-antichymotrypsin is present in diffuse senile plaques. A comparative study of beta-protein and alpha 1-antichymotrypsin immunostaining in the Alzheimer brain.

Authors:  M Shoji; S Hirai; H Yamaguchi; Y Harigaya; K Ishiguro; E Matsubara
Journal:  Am J Pathol       Date:  1991-01       Impact factor: 4.307

3.  A clinical evaluation of serum alpha-1-antichymotrypsin levels in liver disease and cancers.

Authors:  S Matsuzaki; K Iwamura; M Itakura; H Kamiguchi; T Katsunuma
Journal:  Gastroenterol Jpn       Date:  1981-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.